Viimeisin päivitys :
08/05/2024
Vasodilataattorit   Alprostadil  
Injektioneste
Stabilius liuoksessa Stabilius seoksissa Tekijät, jotka vaikuttavat stabiliuteen Yhteensopivuus Antotapa Viitteet Pdf
   Kemiallinen rakenne  

Kauppanimi   Kauppanimi     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfaprostin Egypti
Alistint Marokko
Alpros Turkki
Alprostadil Argentiina, Chile, Ecuador, Espanja, Kanada, Malesia, Marokko, Romania, Saksa, Turkki, Yhdysvallat
Alprostapint Argentiina, Ecuador, Itävalta, Kolumbia, Marokko, Unkari
Alprostar Italia
Aplicav Brasilia
Cardiobon Argentiina, Marokko
Caverject Belgia, Brasilia, Espanja, Etelä-Afrikka, Iso-Britannia, Italia, Itävalta, Kanada, Norja, Portugali, Puola, Ranska, Ruotsi, Slovenia, Sveitsi, Tanska, Turkki, Yhdysvallat
Edex Ranska
Liple Japani
Minprog Itävalta, Saksa
Ostapint Marokko, Meksiko
Palux Japani
Pridax Espanja, Itävalta, Romania, Saksa
Prolisina VR Argentiina
Prostandin Japani
Prostavasin Egypti, Iran, Italia, Itävalta, Luxemburg, Puola, Saksa, Unkari
Prostin VR Australia, Belgia, Hollanti, Iran, Iso-Britannia, Italia, Kanada, Kreikka, Luxemburg, Malesia, Norja, Portugali, Puola, Saudi-Arabia, Suomi, Sveitsi, Tanska, Unkari, Venezuela, Yhdysvallat
Prostine VR Ranska
Vasaprostan Romania
Viitteet   Injektioneste   Viitteet : Alprostadil  
Tyyppi Julkaisu
1072 Lehti Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899 Lehti Trissel LA, Zhang Y.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003 Lehti Paul M, Razzouq N, Tixier G, Astier A.
Stability of prostaglandin E1 (PGE1) in aqueous solutions.
EJHP Science 2005 ; 2: 31-36.
2090 Lehti Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2150 Lehti Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
J Urology 1998 ; 160; 2: 551-555.
2151 Lehti Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F.
Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC).
Int J Pharm 1995 ; 115: 113-117.
3201 Lehti Dice JE.
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448 Lehti Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761 Kirja Chavan E.
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Master en pharmacie - University of Geneva 2014
3961 Lehti McCluskey S.V,Kirkham K,Munson J.M.
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069 Lehti Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F.
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.
EJHP 2018 ; 25, e2
4389 Lehti Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4491 Lehti De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2020
4507 Lehti Ross E, Salinas A, Petty K, Her C, Carpenter J.
Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543 Lehti Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4570 Lehti Greenhill K, Hornsby E, Gorman G.
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Pharmaceuticals 2019
4651 Lehti De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2021 ;180,1169–1176.

  Mentions Légales